About Multiple Sclerosis | Programs & Services | News Center | Publications | Site Preferences | Contact MSAA | Home
Search Clinical Trials Parent Therapeutic Areas: Neurology | Musculoskeletal
Multiple Sclerosis
State
Country
Alabama
Tuscaloosa : Alabama Neurology & Sleep Medicine
Investigational Oral Medication for CIS (Pre-MS)
Various Cities : Research Center New!
FREEDOMS II - Multiple Sclerosis Study
Arizona
Gilbert : Clinical Research Advantage / Neurological Physicians of Arizona
Phoenix : Research Site:
A Dose-Finding Study of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis.
Phoenix : Barrows Neurological Clinic
Phoenix : Xenoscience
Phoenix : Xenoscience Clinical Research Division
Investigational Oral Medication for RRMS
Scottsdale : Dept of Neurology, Mayo Clinic
Tucson : Northwest NeuroSpecialists, PLLC
Clinical Research Study Available for People Diagnosed with Multiple Sclerosis
Multiple Sclerosis Study
California
Auburn : Sutter Institute for Medical Research (SIMR)
Multiple Sclerosis Data Collection Study
Berkeley : Research Site:
Irvine : University of California, Irvine
Loma Linda : Loma Linda University Neurology Clinical Research Center
Modesto : Sutter Gould Medical Foundation
San Francisco : Research Site:
Colorado
Centennial : 1st International Clinical Research Center
Do you have Relapsing Remitting Multiple Sclerosis?
Connecticut
Fairfield : Associated Neurologists of Southern CT
Florida
Bradenton : Research Site:
Bradenton : Bradenton Research
Bradenton Neurology, Inc. is participating in a nationwide research study for individuals who have been diagnosed with Multiple Sclerosis.
Maitland : Neurology Associates, P.A.
Maitland : Neurology Associates
Sarasota : Negroski, Stein, Sutherland & Hanes Neurology.
St Petersburg : Suncoast Neruoscience Associates Inc.
Sunrise : Neurology Clinical Research Inc.
Tampa : Meridien Research
Vero Beach : Research Site:
Georgia
Atlanta : Research Site:
Atlanta : Neurotrials Research, Inc.
Have you experienced symptoms that suggest multiple sclerosis?
Atlanta : NeuroTrials Research, Inc.
Suwanee : Georgia Neurology & Sleep Medicine
Illinois
Chicago : Research Site:
Chicago : Northwestern University, Deptartment of Neurology
Elk Grove Village : Suburban Neurologists, SC
Flossmoor : South Suburban Neurology
Indiana
Fort Wayne : Fort Wayne Neurological Center
Indianapolis : Josephson Wallack Munshower Neurology, PC
Indianapolis : JWM Neurology PC
Iowa
Des Moines : Ruan Neurology & Research Center
Kansas
Kansas City : Research Site:
Lenexa : MidAmerica Neuroscience Institute
Relapsing forms of Multiple Sclerosis study to evaluate the safety and tolerability of two doses of an oral study drug over 24 weeks (study 7)
Kentucky
Lexington : Associates in Neurology, P.S.C.
A Phase 2 study of LY2127399, an AntiBaff Human Antibody vs placebo for subjects with Relapsing Remitting Multiple Sclerosis
A Phase 3 study of PEGylated Interferon Beta-1a vs Placebo for subjects with Relapsing Remitting Multiple Sclerosis.
Lexington : Baptist Neurology Center
Lexington : University of Kentucky
Louisiana
Shreveport : LSUHSC Dept of Neurology
Maryland
Baltimore : Research Site:
Massachusetts
Michigan
Clinton Twp. : Michigan Neurology Associates, P.C.
Farmington Hills : Research Site:
Grand Rapids : Michigan Medical P.C. Neurology
Grand Rapids : St Mary's Healthcare
Grand Rapids : St. Mary's Healthcare
Traverse City : Northern Michigan Neurology
Minnesota
Minneapolis : University of Minnesota Dept. of Neurology
Mississippi
Missouri
St. Louis : Saint Louis University, Dept of Neurology
Montana
Billings : Billings Clinic Research Center
Are you between the age of 18 and 65 with a diagnosis of Multiple Sclerosis?
New Hampshire
Lebanon : Research Site:
New Jersey
Lawrenceville : AdvanceMed Research
The Dignity studies are phase III international multicenter, double-blind, randomized, placebo-controlled trials of botulinum toxin (BOTOX) in patients with spinal cord injury (SCI) or multiple sclerosis (MS); BOTOX is not yet licensed for these indications.
New Mexico
Albuquerque : Research Site:
Albuquerque : MS Specialty Clinic UNM
New York
Albany : Upstate Clinical Research, LLC
Latham : Multiple Sclerosis Center of NE New York Empire Neurology, P.C.
Mineola : Winthrop University Hospital Clinical Trials Center
Relapsing remitting multiple sclerosis
Volunteers needed for a multiple sclerosis research study
New York : Mount Sinai Medical Center
A 21 WEEK STUDY TO EVALUATE SAFETY AND EFFICACY OF ORAL FAMPRIDINE-SR IN SUBJECTS WITH MULTIPLE SCLEROSIS.
A 24-month, double-blind, randomized, multi-center, placebo-controlled, parallel-group study comparing the efficacy and safety of FTY720 1.25mg and 0.5mg administered once daily versus placebo in patients with relapsing remitting multiple sclerosis
New York : Research Site:
A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon beta 1-a and Glatiramer Acetate to Either Agent Alone in Patients with Relapsing-Remitting Multiple Sclerosis (CombiRx Phase III)
A Phase II/III, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Primary Progressive Multiple Sclerosis PROTOCOL: U2786g
New York : Mount Sinai School of Medicine; Corinne Goldsmith Dickinson Center for MS
ITN020AI: A Randomized, Double Blind, Placebo Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Atorvastatin in Patient with Clinically Isolated Syndrome and High Risk of Conversion to Multiple Sclerosis (MS) (STAYCIS)
OMEGA-Oral Megadose Corticosteroid Therapy of Acute Exacerbations in Multiple Sclerosis
The Establishment of a Patient Registry and Initiation of Related Projects of the New York State Multiple Sclerois Consortium
Plainview : Research Site:
Schenectady : Schenectady Neurological Consultants, PC
The TYSABRI Global Observational Program in Safety (TYGRIS) is a safety observational cohort study designed to obtain long-term safety data in multiple sclerosis (MS) patients treated with TYSABRI in a clinical practice setting.
Stony Brook : Research Site:
Stony Brook : SUNY Stony Brook Dept of Neurology
Syracuse : Institute of Human Performance SUNY Upstate New York University
North Carolina
Charlotte : Research Site:
Charlotte : The Neurological Institute, P.A.
Charlotte : The Neurological Institute
Salisbury : Central Carolina Neurology & Sleep, PA
Looking for MS Patients for a Quality of Life Study
Winston-Salem : Wake Forest University Health Sciences
North Dakota
Bismarck : DakotaNeurology Legacy Pharma Research
Ohio
Cincinnati : Riverhills Healthcare Inc.
Cleveland : Research Site:
Columbus : Research Site:
Dayton : Neurology Specialists LLC
Oklahoma
Tulsa : Neurological Associates of Tulsa
Oregon
Portland : Providence MS Center
Tualatin : Research Site:
Pennsylvania
Allentown : St. Luke's Center for Neuroscience MS Center
Philadelphia : Albert Einstein Medical Center, Neurosensory Sciences
Philadelphia : Drexel University College of Medicine, Department of Neurology
Philadelphia : The Comprehensive MS Center at Thomas Jefferson University
Philadelphia : Drexel University College of Medicine Department of Neurology
Philadelphia : Jefferson Neurology Associates
South Carolina
Greenville : Alliance for NeuroResearch, LLC Absher Neurology, P.A.
Tennessee
Cordova : Neurology Clinic P.C.
Nashville : Research Site:
Nashville : Vanderbilt Multiple Sclerosis Center
Texas
Houston : Research Site:
Houston : Kelsey Research Foundation
Round Rock : MS Clinic of Central Texas
San Antonio : Research Site:
San Antonio : Integra Clinical Research, LLC
Vermont
Burlington : Research Site:
Burlington : Fletcher Allen Health Care, Dept of Neurology
Virginia
Charlottesville : Research Site:
Washington
Seattle : University of Washington
Washington, DC
Washington : George Washington University, Dept of Neurology
West Virginia
Charleston : Capitol Neurology
Wisconsin
Milwaukee : Regional MS Center at St. Lukes Medical Center
Belgium
Edegem : Research Site:
Sijsele-Damme : Research Site:
Bulgaria
Sofia : Research Site:
Canada
Montreal, QC : Research Site:
Toronto, ON : Research Site:
Vancouver, BC : Research Site:
Czech Republic
Ostrava : Research Site:
Pardubice : Research Site:
Prague : Research Site:
Praha : Research Site:
Teplice : Research Site:
Denmark
Arhus : Research Site:
Finland
Helsinki : Research Site:
Turku : Research Site:
France
Bordeaux : Research Site:
Caen : Research Site:
Clermont-Ferrand : Research Site:
Lyon : Research Site:
Montpellier : Research Site:
Nimes : Research Site:
Germany
Berlin : Research Site:
Hamburg : Research Site:
Marburg : Research Site:
Tübingen : Research Site:
Ulm : Research Site:
Italy
Milano : Research Site:
Roma : Research Site:
Mexico
Aguascalientes : Research Site:
Chihuahua : Research Site:
Netherlands
Breda : Research Site:
Poland
Gdansk : Research Site:
Lodz : Research Site:
Lublin : Research Site:
Warszawa : Research Site:
Romania
Bucuresti : Research Site:
Targu Mures : Research Site:
Russian Federation
Ekaterinburg : Research Site:
Kazan : Research Site:
Moscow : Research Site:
Nizhny Novgorod : Research Site:
Tyumen : Research Site:
Serbia and Montenegro
Belgrade : Research Site:
Nis : Research Site:
Nova Sad : Research Site:
Slovakia
Banska Bystrica : Research Site:
Bratislava : Research Site:
Kosice : Research Site:
Nitra : Research Site:
Spisska Nova Ves : Research Site:
Spain
Barcelona : Research Site:
Madrid : Research Site:
Malaga : Research Site:
Sevilla : Research Site:
Valencia : Research Site:
Switzerland
Basel : Research Site:
Ukraine
Kharkov : Research Site:
Kiev : Research Site:
Propetrovsk : Research Site:
Vinnytsya : Research Site:
United Kingdom
Liverpool : Research Site:
Newcastle upon Tyne : Research Site:
Nottingham : Research Site:
Sheffield : Research Site:
